Key takeaways
What matters most
- The tracker should mirror the prescription instead of suggesting a schedule.
- Record routine entries, photos, and personal observations without guessing at their meaning.
- Bring questions and relevant notes to the prescriber who manages the treatment.
Enter the medication name as written, the date you began recording, and the routine exactly as your prescriber directed. A tracker is a record of those instructions, not a dosing guide.
If the prescription changes, date the change and update future reminders. Keep the older entries as they were so the timeline stays honest.
- Prescription name and form.
- Date tracking began.
- Prescribed routine copied accurately.
- Date of any later instruction change.
Mark a scheduled entry complete when you record completing it. Leave uncertain entries blank or add a short note. Avoid rebuilding a long stretch from memory.
Questions about a missed dose, a side effect, or a treatment change belong with the prescriber or pharmacist. Plume should not answer them or adjust the routine.
Take a dated baseline and repeat the same hairline, temple, top, and crown views. Keep the lighting, camera position, hair state, and styling as consistent as you can.
Use short notes for things you personally notice and want to remember. This can include sexual symptoms, mood changes, breast changes, testicular pain, a tracking gap, a haircut, or a question for the next appointment. A note does not prove that the medicine caused the observation.
The United States label for oral finasteride 1 milligram is for male pattern hair loss in men only. It is not indicated for women or children. The label also warns that people who are pregnant or may become pregnant should not handle crushed or broken tablets because of risk to a male fetus.
The label lists sexual adverse reactions and includes postmarketing reports of persistent sexual dysfunction, depression, suicidal thoughts and behavior, breast changes, testicular pain, and fertility related effects. It also says finasteride can affect PSA test results. The FDA states that there is no FDA approved topical finasteride product.
